No products in the cart.
TikTok’s cortisol face trend meets endocrine reality
1. TikTok’s “cortisol face” trend has led more patients to request cortisol testing for facial puffiness, weight gain, or stress-related...
Semaglutide (Ozempic) raises questions about mood and nonresponse
1. Reports of emotional flattening among some users of semaglutide (Ozempic) have brought new attention to how glucagon-like peptide-1 receptor...
Cruise ship hantavirus outbreak turns into a global contact tracing test
1. An Andes virus outbreak aboard the MV Hondius expedition cruise ship led to severe respiratory illness, multiple deaths, and...
Celebrity body scans are colliding with radiology evidence
1. Celebrity endorsements have helped turn whole-body magnetic resonance imaging into a high-cost consumer screening trend for asymptomatic adults. 2....
The Scan by 2 Minute Medicine®: celebrity whole-body MRI craze floods clinics, cruise ship hantavirus outbreak prompts global tracing, “Ozempic personality” raises new questions, and TikTok’s “cortisol face” trend drives endocrine workups
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers....
Pediatric hospitals adopt generative AI for documentation and care coordination
Pediatric hospitals are beginning to use generative AI for documentation, care coordination, and workflow support, with near-term value in reducing...
Hospitals face a new test of artificial intelligence governance
1. The Joint Commission has launched a voluntary certification program focused on responsible artificial intelligence use in healthcare organizations. 2....
Food and Drug Administration reviews model for predicting drug related liver injury
1. The Food and Drug Administration is reviewing an artificial intelligence based tool that could help predict drug induced liver...
2MM: AI Roundup: Food and Drug Administration reviews liver injury prediction tool, Joint Commission launches healthcare artificial intelligence certification, governance playbooks aim to standardize adoption, and pediatric hospitals bring generative tools to the frontline
Food and Drug Administration reviews artificial intelligence tool for liver injury prediction The Food and Drug Administration (FDA) is reviewing...
Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment
1. Gilead reported positive phase 3 IDEAL data for seladelpar (Livdelzi) in patients with primary biliary cholangitis who had persistent...
